Cansortium (CNTMF, $0.19) was a top loser over the last three months, falling -2 to $0.19 per share. A.I.dvisor analyzed 288 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending May 2, 2024, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.